How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation
出版年份 2020 全文链接
标题
How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation
作者
关键词
-
出版物
BLOOD
Volume 135, Issue 19, Pages 1619-1629
出版商
American Society of Hematology
发表日期
2020-03-23
DOI
10.1182/blood.2019000956
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- In vitro comparison of currently available and investigational antiviral agents against pathogenic human double-stranded DNA viruses: A systematic literature review
- (2019) Roy F. Chemaly et al. ANTIVIRAL RESEARCH
- The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT
- (2019) Martin Schmidt-Hieber et al. ANNALS OF HEMATOLOGY
- Use of Leflunomide for Treatment of Cytomegalovirus Infection in Recipients of Allogeneic Stem Cell Transplant
- (2019) Anant Gokarn et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient
- (2019) Susanne Jung et al. BMC INFECTIOUS DISEASES
- Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)
- (2019) Per Ljungman et al. LANCET INFECTIOUS DISEASES
- Potential Application of TALENs against Murine Cytomegalovirus Latent Infections
- (2019) Chen et al. Viruses-Basel
- New vaccines and antiviral drugs for cytomegalovirus
- (2019) Paul Griffiths JOURNAL OF CLINICAL VIROLOGY
- Maribavir for Preemptive Treatment of Cytomegalovirus Reactivation
- (2019) Johan Maertens et al. NEW ENGLAND JOURNAL OF MEDICINE
- Valganciclovir Pharmacokinetics in Patients Receiving Oral Prophylaxis Following Kidney Transplantation and Model-Based Predictions of Optimal Dosing Regimens
- (2018) Thomas Tängdén et al. CLINICAL PHARMACOKINETICS
- Assessing the risk of CMV reactivation and reconstitution of antiviral immune response post bone marrow transplantation by the QuantiFERON-CMV-assay and real time PCR
- (2018) Adalbert Krawczyk et al. JOURNAL OF CLINICAL VIROLOGY
- T-Track-CMV and QuantiFERON-CMV assays for prediction of protection from CMV reactivation in kidney transplant recipients
- (2018) Smaranda Gliga et al. JOURNAL OF CLINICAL VIROLOGY
- Quantiferon-Cytomegalovirus assay: A potentially useful tool in the evaluation of CMV-specific CD8+ T-cell reconstitution in pediatric hematopoietic stem cell transplant patients
- (2018) Bilio Paouri et al. PEDIATRIC TRANSPLANTATION
- Assessment of the T-SPOT.CMV interferon-γ release assay in renal transplant recipients: A single center cohort study
- (2018) Dimitrios Chanouzas et al. PLoS One
- Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study
- (2018) Bernhard Banas et al. TRANSPLANT INTERNATIONAL
- Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials
- (2018) Roy F Chemaly et al. CLINICAL INFECTIOUS DISEASES
- Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study
- (2018) Genovefa A Papanicolaou et al. CLINICAL INFECTIOUS DISEASES
- The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients
- (2018) Lynn El Haddad et al. JOURNAL OF INFECTIOUS DISEASES
- A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation
- (2018) Francisco M. Marty et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation
- (2017) Ifigeneia Tzannou et al. JOURNAL OF CLINICAL ONCOLOGY
- Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT
- (2017) M Neuenhahn et al. LEUKEMIA
- Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
- (2017) Francisco M. Marty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Usefulness of Monitoring Cytomegalovirus-Specific Immunity by Quantiferon-CMV in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients
- (2017) Sae-Mi Lee et al. Annals of Laboratory Medicine
- Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients: A case series
- (2016) Firas El Chaer et al. ANTIVIRAL RESEARCH
- Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
- (2016) P. Teira et al. BLOOD
- How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients
- (2016) F. El Chaer et al. BLOOD
- Are We There Yet? Impact of the First International Standard for Cytomegalovirus DNA on the Harmonization of Results Reported on Plasma Samples
- (2016) Jutta K. Preiksaitis et al. CLINICAL INFECTIOUS DISEASES
- Quantiferon CMV assay in allogenic stem cell transplant patients
- (2016) Patrizia Bono et al. JOURNAL OF CLINICAL VIROLOGY
- Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial
- (2016) Ryotaro Nakamura et al. Lancet Haematology
- Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study
- (2016) Margaret L Green et al. Lancet Haematology
- Efficacy and Safety of a Preemptive Antiviral Therapy Strategy Based on Combined Virological and Immunological Monitoring for Active Cytomegalovirus Infection in Allogeneic Stem Cell Transplant Recipients
- (2016) David Navarro et al. Open Forum Infectious Diseases
- Valganciclovir for the Prevention of Complications of Late Cytomegalovirus Infection After Allogeneic Hematopoietic Cell Transplantation
- (2015) Michael Boeckh et al. ANNALS OF INTERNAL MEDICINE
- Recent Advances in Cytomegalovirus: An Update on Pharmacologic and Cellular Therapies
- (2015) Michael Boeckh et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Preventing stem cell transplantation-associated viral infections using T-cell therapy
- (2015) Ifigeneia Tzannou et al. Immunotherapy
- Combination therapy for multidrug-resistant cytomegalovirus disease
- (2015) C. Stuehler et al. Transplant Infectious Disease
- Diagnosis and treatment of cytomegalovirus 2013
- (2014) Hermann Einsele et al. CURRENT OPINION IN HEMATOLOGY
- CMV Prophylaxis in Hematopoietic-Cell Transplantation
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections after HSCT
- (2014) A. Papadopoulou et al. Science Translational Medicine
- Geno- and Phenotypic Characterization of Human Cytomegalovirus Mutants SelectedIn Vitroafter Letermovir (AIC246) Exposure
- (2013) Thomas Goldner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cytomegalovirus diseases after hematopoietic stem cell transplantation: A mini-review
- (2013) Ella J. Ariza-Heredia et al. CANCER LETTERS
- T lymphocytes targeting native receptors
- (2013) Cliona M. Rooney et al. IMMUNOLOGICAL REVIEWS
- High Rate of Cytomegalovirus Drug Resistance Among Patients Receiving Preemptive Antiviral Treatment After Haploidentical Stem Cell Transplantation
- (2013) Einat Shmueli et al. JOURNAL OF INFECTIOUS DISEASES
- CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation
- (2013) Francisco M. Marty et al. NEW ENGLAND JOURNAL OF MEDICINE
- New algorithm for valganciclovir dosing in pediatric solid organ transplant recipients
- (2013) A. Åsberg et al. PEDIATRIC TRANSPLANTATION
- Clinical Assessment of Anti-Viral CD8+ T Cell Immune Monitoring Using QuantiFERON-CMV® Assay to Identify High Risk Allogeneic Hematopoietic Stem Cell Transplant Patients with CMV Infection Complications
- (2013) Siok-Keen Tey et al. PLoS One
- Efficacy of a Viral Load-Based, Risk-Adapted, Preemptive Treatment Strategy for Prevention of Cytomegalovirus Disease after Hematopoietic Cell Transplantation
- (2012) Margaret L. Green et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and Coronavirus
- (2012) Hans H. Hirsch et al. CLINICAL INFECTIOUS DISEASES
- A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2012) Mohamed A Kharfan-Dabaja et al. LANCET INFECTIOUS DISEASES
- Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation
- (2011) Dana G. Wolf et al. ANTIVIRAL RESEARCH
- Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients
- (2011) F. Milano et al. BLOOD
- Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs
- (2011) H. Nakamae et al. HAEMATOLOGICA
- Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
- (2011) Francisco M Marty et al. LANCET INFECTIOUS DISEASES
- Maribavir and human cytomegalovirus—what happened in the clinical trials and why might the drug have failed?
- (2011) Francisco M Marty et al. Current Opinion in Virology
- Decreased Infections in Recipients of Unrelated Donor Hematopoietic Cell Transplantation from Donors with an Activating KIR Genotype
- (2010) Marcie Tomblyn et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Evidence for a Bidirectional Relationship between Cytomegalovirus Replication and acute Graft-versus-Host Disease
- (2010) Nathan Cantoni et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- An International Comparison of Current Strategies to Prevent Herpesvirus and Fungal Infections in Hematopoietic Cell Transplant Recipients
- (2010) Margaret Pollack et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Immune monitoring with iTAg MHC Tetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: a prospective multicenter study
- (2010) J. W. Gratama et al. BLOOD
- Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation
- (2010) T. Feuchtinger et al. BLOOD
- Drug-resistant cytomegalovirus in transplant recipients: a French cohort study
- (2010) S. Hantz et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Incidence, Risk Factors, and Outcome of Cytomegalovirus Infection and Disease in Patients Receiving Prophylaxis with Oral Valganciclovir or Intravenous Ganciclovir after Umbilical Cord Blood Transplantation
- (2009) Pau Montesinos et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients
- (2009) W. Zhou et al. BLOOD
- How we treat cytomegalovirus in hematopoietic cell transplant recipients
- (2009) M. Boeckh et al. BLOOD
- Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus
- (2009) T. Allice et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More